CAMTEK LTD (CAMT) Stock Fundamental Analysis

NASDAQ:CAMT • IL0010952641

153 USD
-0.19 (-0.12%)
Last: Feb 20, 2026, 10:31 AM
Fundamental Rating

5

CAMT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. CAMT scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, CAMT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • CAMT had positive earnings in the past year.
  • Of the past 5 years CAMT 4 years were profitable.
  • Of the past 5 years CAMT 4 years had a positive operating cash flow.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.88%, CAMT is in the better half of the industry, outperforming 61.06% of the companies in the same industry.
  • The Return On Equity of CAMT (8.27%) is better than 68.14% of its industry peers.
  • The Return On Invested Capital of CAMT (10.44%) is better than 81.42% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CAMT is in line with the industry average of 10.70%.
Industry RankSector Rank
ROA 3.88%
ROE 8.27%
ROIC 10.44%
ROA(3y)11.69%
ROA(5y)10.59%
ROE(3y)19.64%
ROE(5y)17.8%
ROIC(3y)11.45%
ROIC(5y)11.22%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • CAMT has a better Profit Margin (9.86%) than 65.49% of its industry peers.
  • In the last couple of years the Profit Margin of CAMT has grown nicely.
  • With an excellent Operating Margin value of 26.59%, CAMT belongs to the best of the industry, outperforming 84.96% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CAMT has grown nicely.
  • CAMT has a better Gross Margin (50.67%) than 63.72% of its industry peers.
  • In the last couple of years the Gross Margin of CAMT has remained more or less at the same level.
Industry RankSector Rank
OM 26.59%
PM (TTM) 9.86%
GM 50.67%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.3%
PM growth 5Y10.97%
GM growth 3Y-0.66%
GM growth 5Y0.65%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

  • CAMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for CAMT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • CAMT has an Altman-Z score of 8.34. This indicates that CAMT is financially healthy and has little risk of bankruptcy at the moment.
  • CAMT has a better Altman-Z score (8.34) than 68.14% of its industry peers.
  • CAMT has a Debt/Equity ratio of 0.90. This is a neutral value indicating CAMT is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.90, CAMT is not doing good in the industry: 84.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 8.34
ROIC/WACC0.84
WACC12.36%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • CAMT has a Current Ratio of 7.58. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of CAMT (7.58) is better than 85.84% of its industry peers.
  • CAMT has a Quick Ratio of 6.52. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
  • CAMT's Quick ratio of 6.52 is amongst the best of the industry. CAMT outperforms 85.84% of its industry peers.
Industry RankSector Rank
Current Ratio 7.58
Quick Ratio 6.52
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

  • CAMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.23%, which is quite good.
  • CAMT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 38.06% yearly.
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.23%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.24% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 15.15% on average over the next years. This is quite good.
EPS Next Y5.77%
EPS Next 2Y10.58%
EPS Next 3Y12.83%
EPS Next 5Y14.24%
Revenue Next Year6.12%
Revenue Next 2Y10.27%
Revenue Next 3Y13.94%
Revenue Next 5Y15.15%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 47.66, the valuation of CAMT can be described as expensive.
  • Based on the Price/Earnings ratio, CAMT is valued a bit cheaper than 68.14% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.09. CAMT is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 45.07 indicates a quite expensive valuation of CAMT.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CAMT is on the same level as its industry peers.
  • CAMT is valuated expensively when we compare the Price/Forward Earnings ratio to 27.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 47.66
Fwd PE 45.07
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CAMT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.2
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CAMT does not grow enough to justify the current Price/Earnings ratio.
  • CAMT has a very decent profitability rating, which may justify a higher PE ratio.
  • CAMT's earnings are expected to grow with 12.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.27
PEG (5Y)1.25
EPS Next 2Y10.58%
EPS Next 3Y12.83%

0

5. Dividend

5.1 Amount

  • No dividends for CAMT!.
Industry RankSector Rank
Dividend Yield 0%

CAMTEK LTD

NASDAQ:CAMT (2/20/2026, 10:31:05 AM)

153

-0.19 (-0.12%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-18
Earnings (Next)05-11
Inst Owners56.76%
Inst Owner Change-1.12%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap7.00B
Revenue(TTM)N/A
Net Income(TTM)47.83M
Analysts82.22
Price Target140.17 (-8.39%)
Short Float %11.92%
Short Ratio7.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.33
Dividend Growth(5Y)56.74%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.07%
Min EPS beat(2)-2.25%
Max EPS beat(2)0.11%
EPS beat(4)3
Avg EPS beat(4)-0.13%
Min EPS beat(4)-2.25%
Max EPS beat(4)1.1%
EPS beat(8)7
Avg EPS beat(8)2.65%
EPS beat(12)10
Avg EPS beat(12)2.33%
EPS beat(16)12
Avg EPS beat(16)1.76%
Revenue beat(2)0
Avg Revenue beat(2)-0.94%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-0.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-0.07%
Revenue beat(8)2
Avg Revenue beat(8)-0.4%
Revenue beat(12)2
Avg Revenue beat(12)-0.61%
Revenue beat(16)3
Avg Revenue beat(16)-0.75%
PT rev (1m)9.13%
PT rev (3m)16.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 47.66
Fwd PE 45.07
P/S 14.44
P/FCF N/A
P/OCF N/A
P/B 12.11
P/tB 14.21
EV/EBITDA 46.2
EPS(TTM)3.21
EY2.1%
EPS(NY)3.4
Fwd EY2.22%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.6
BVpS12.63
TBVpS10.77
PEG (NY)8.27
PEG (5Y)1.25
Graham Number30.2
Profitability
Industry RankSector Rank
ROA 3.88%
ROE 8.27%
ROCE 11.59%
ROIC 10.44%
ROICexc 24.55%
ROICexgc 29.94%
OM 26.59%
PM (TTM) 9.86%
GM 50.67%
FCFM N/A
ROA(3y)11.69%
ROA(5y)10.59%
ROE(3y)19.64%
ROE(5y)17.8%
ROIC(3y)11.45%
ROIC(5y)11.22%
ROICexc(3y)25.55%
ROICexc(5y)36.34%
ROICexgc(3y)29.2%
ROICexgc(5y)38.7%
ROCE(3y)12.72%
ROCE(5y)12.46%
ROICexgc growth 3Y-28.75%
ROICexgc growth 5Y-9.85%
ROICexc growth 3Y-32.98%
ROICexc growth 5Y-13.04%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.3%
PM growth 5Y10.97%
GM growth 3Y-0.66%
GM growth 5Y0.65%
F-ScoreN/A
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA 3.72
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.58
Quick Ratio 6.52
Altman-Z 8.34
F-ScoreN/A
WACC12.36%
ROIC/WACC0.84
Cap/Depr(3y)147.58%
Cap/Depr(5y)141.77%
Cap/Sales(3y)2.54%
Cap/Sales(5y)2.17%
Profit Quality(3y)82.23%
Profit Quality(5y)89.41%
High Growth Momentum
Growth
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
EPS Next Y5.77%
EPS Next 2Y10.58%
EPS Next 3Y12.83%
EPS Next 5Y14.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.23%
Revenue Next Year6.12%
Revenue Next 2Y10.27%
Revenue Next 3Y13.94%
Revenue Next 5Y15.15%
EBIT growth 1Y34.63%
EBIT growth 3Y16.61%
EBIT growth 5Y38.61%
EBIT Next Year17.16%
EBIT Next 3Y15.19%
EBIT Next 5Y18.19%
FCF growth 1Y57.45%
FCF growth 3Y25.37%
FCF growth 5Y36.9%
OCF growth 1Y54.1%
OCF growth 3Y26.1%
OCF growth 5Y37.77%

CAMTEK LTD / CAMT FAQ

What is the fundamental rating for CAMT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CAMT.


What is the valuation status of CAMTEK LTD (CAMT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CAMTEK LTD (CAMT). This can be considered as Overvalued.


How profitable is CAMTEK LTD (CAMT) stock?

CAMTEK LTD (CAMT) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for CAMT stock?

The Price/Earnings (PE) ratio for CAMTEK LTD (CAMT) is 47.66 and the Price/Book (PB) ratio is 12.11.


What is the financial health of CAMTEK LTD (CAMT) stock?

The financial health rating of CAMTEK LTD (CAMT) is 5 / 10.